By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Guanhao Biotech Co.,Ltd. (300238.SZ)

SHZ Currency in CNY
¥16.72
-¥0.03
-0.18%
Last Update: 1 Sept 2025, 03:38
¥4.43B
Market Cap
101.33
P/E Ratio (TTM)
Forward Dividend Yield
¥9.33 - ¥19.98
52 Week Range

300238.SZ Stock Price Chart

Explore Guanhao Biotech Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300238.SZ price movements and trends.

300238.SZ Company Profile

Discover essential business fundamentals and corporate details for Guanhao Biotech Co.,Ltd. (300238.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

6 Jul 2011

Employees

535.00

CEO

Feng Zhao

Description

Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.

300238.SZ Financial Timeline

Browse a chronological timeline of Guanhao Biotech Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 22 Apr 2025

EPS came in at ¥0.06 , while revenue for the quarter reached ¥94.80M .

Earnings released on 26 Mar 2025

EPS came in at -¥0.00 , while revenue for the quarter reached ¥99.35M .

Earnings released on 28 Oct 2024

EPS came in at ¥0.03 , while revenue for the quarter reached ¥88.44M .

Earnings released on 28 Aug 2024

EPS came in at ¥0.02 , while revenue for the quarter reached ¥97.16M .

Earnings released on 25 Apr 2024

EPS came in at ¥0.05 , while revenue for the quarter reached ¥90.59M .

Earnings released on 6 Mar 2024

EPS came in at -¥0.04 , while revenue for the quarter reached ¥93.99M .

Earnings released on 24 Oct 2023

EPS came in at ¥0.04 , while revenue for the quarter reached ¥98.13M .

Earnings released on 22 Aug 2023

EPS came in at ¥0.03 , while revenue for the quarter reached ¥98.13M .

Earnings released on 19 Apr 2023

EPS came in at -¥0.29 , while revenue for the quarter reached ¥83.30M .

Earnings released on 31 Mar 2023

EPS came in at ¥0.08 , while revenue for the quarter reached ¥112.68M .

Earnings released on 27 Oct 2022

EPS came in at ¥0.05 , while revenue for the quarter reached ¥91.11M .

Earnings released on 25 Aug 2022

EPS came in at -¥1.00 , while revenue for the quarter reached ¥79.95M .

Earnings released on 14 Apr 2022

EPS came in at ¥0.08 , while revenue for the quarter reached ¥116.99M .

Earnings released on 31 Mar 2022

EPS came in at ¥0.08 , while revenue for the quarter reached ¥122.93M .

Earnings released on 14 Oct 2021

EPS came in at ¥0.08 , while revenue for the quarter reached ¥109.59M .

Earnings released on 25 Aug 2021

EPS came in at ¥0.08 , while revenue for the quarter reached ¥133.96M .

Earnings released on 9 Apr 2021

EPS came in at ¥0.07 , while revenue for the quarter reached ¥128.44M .

Earnings released on 9 Mar 2021

EPS came in at ¥0.04 , while revenue for the quarter reached ¥117.91M .

Earnings released on 26 Oct 2020

EPS came in at ¥0.04 , while revenue for the quarter reached ¥115.44M .

300238.SZ Stock Performance

Access detailed 300238.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run